PFIZER INC: Goldman Sachs is not inspired by the file

0








Goldman Sachs research confirms his advice and maintains his neutral opinion on the matter. The price target has been revised downwards to 50 USD against 54 USD previously.

Zonebourse with dpa-AFX Analyzer 2022

All the news about PFIZER, INC.

Analyst Recommendations for PFIZER, INC.

2021 turnover 81,781M
–
71,509M
2021 net result 22,567M
–
19,732M
Net debt 2021 29,099M
–
25,444M
PER 202113.2x
2021 performance3.08%
Capitalization 289 billion
289 billion
253 billion
VE / CA 20213.89x
VE / CA 20222.70x
Number of employees78,500
Floating59.3%


Hard :

Period:




Pfizer, Inc.: Pfizer, Inc. Technical Analysis Chart | Market area

Trends Technical Analysis PFIZER, INC.

Short termMiddle termLong term
Trendsbearishbullishbullish

Evolution of the Income Statement

Sale

Purchase

Average recommendationACCUMULATE
Number of Analysts23
Last Closing Price

$51.47

Average price target

$57.83

Deviation / Average Target 12.4%

Officers and Directors




Source link -88